SAN DIEGO, June 16 /PRNewswire-FirstCall/ -- Biosite Incorporated
(Nasdaq: BSTE) today announced that Gunars Valkirs, Ph.D, senior vice
president, Biosite Discovery, will discuss the Company's operating
environment, products and research and development activities at Nasdaq's
17th Annual Investor Program. The conference will be held at the
Renaissance Chancery Court in London. Biosite's presentation will take
place June 21, 2006, at 4:30 p.m. Greenwich Mean Time.
A link to the live audio webcast can be accessed through the Biosite
website, http://www.biosite.com. The Biosite presentation will be archived on the
website until July 12, 2006 in the Investor Center under Events Calendar.
About Biosite Incorporated
Biosite Incorporated is a leading bio-medical company commercializing
proteomics discoveries for the advancement of medical diagnosis. The
Company's products contribute to improvements in medical care by aiding
physicians in the diagnosis of critical diseases and health conditions.
Biosite's Triage(R) rapid diagnostics are used in approximately 50 percent
of U.S. hospitals and in more than 60 international markets. Information on
Biosite can be found at http://www.biosite.com.
Biosite(R), Triage(R) and New Dimensions in Diagnosis(R) are registered
trademarks of Biosite Incorporated. The Company's logo is a trademark of
Biosite Incorporated.
SOURCE Biosite Incorporated
 back to top
Related links:
http://www.biosite.com
http://www.prnewswire.com/comp/116737.html /
CONTACT:
Nadine Padilla, Vice President, Corporate and
Investor Relations of Biosite Incorporated, +1-858-805-2820,
npadilla@biosite.com
|
